| Absorption |
| Blood-Brain Barrier | BBB- | 0.9659 |
| Human Intestinal Absorption | HIA+ | 0.9545 |
| Caco-2 Permeability | Caco2+ | 0.8867 |
| P-glycoprotein Substrate | Substrate | 0.7862 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8782 |
| Non-inhibitor | 0.8383 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.7489 |
| Distribution |
| Subcellular localization | Lysosome | 0.7248 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8468 |
| CYP450 2D6 Substrate | Non-substrate | 0.9116 |
| CYP450 3A4 Substrate | Non-substrate | 0.6386 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9045 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9070 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9268 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9026 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8309 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7726 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8402 |
| Non-inhibitor | 0.8660 |
| AMES Toxicity | AMES toxic | 0.7844 |
| Carcinogens | Non-carcinogens | 0.9033 |
| Fish Toxicity | High FHMT | 0.9975 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9407 |
| Honey Bee Toxicity | Low HBT | 0.8853 |
| Biodegradation | Not ready biodegradable | 1.0000 |
| Acute Oral Toxicity | III | 0.7916 |
| Carcinogenicity (Three-class) | Non-required | 0.6211 |